Latest News

LSTM led partnership receives funding to develop drug for treating two neglected tropical diseases

An LSTM led partnership has been awarded nearly £1.5 million from the Medical Research Council for the pre-clinical development of a candidate drug to treat onchocerciasis and lymphatic filariasis, by targeting the bacterial symbiont Wolbachia.

Source link

Related posts

US Lifts Visa Halt to Boost COVID-19 Physician Workforce


Alcohol-related cirrhosis mortality on the rise among young adults


Medical News Today: What causes rosy cheeks?


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy